Supernus to Attend FBR HealthCare Conference in September

By GlobeNewswire,  August 19, 2014, 10:00:00 AM EDT


ROCKVILLE, Md., Aug. 19, 2014 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq:SUPN), a specialty pharmaceutical company, today announced that the Company's management will be hosting investor meetings during the FBR Healthcare Conference.

Date: Wednesday, September 3
Place: Four Seasons Hotel, Boston

Investors interested in arranging a meeting during this conference should contact the FBR meeting coordinator.

About Supernus Pharmaceuticals, Inc.

Supernus Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system, or CNS, diseases. The Company has two marketed products for epilepsy, Oxtellar XR® (extended-release oxcarbazepine) and Trokendi XR™ (extended-release topiramate). The Company is also developing several product candidates in psychiatry to address large market opportunities in ADHD, including ADHD patients with impulsive aggression. These product candidates include SPN-810 for impulsive aggression in ADHD and SPN-812 for ADHD.

CONTACT: Jack A. Khattar, President and CEO
         Gregory S. Patrick, Vice President and CFO
         Supernus Pharmaceuticals, Inc.
         301-838-2591
         or
         Investor Contact:
         Cockrell Group
         877-889-1972
         investorrelations@thecockrellgroup.com
         cockrellgroup.com

Source: Supernus Pharmaceuticals, Inc.

This article appears in: News Headlines

Referenced Stocks: SUPN


Latest News Video





Most Active by Volume

Company Last Sale Change Net / %
F $ 15.11 1.22 ▼ 7.47%
BAC $ 17.01 0.02 ▼ 0.12%
TIBX $ 23.65 4.14 ▲ 21.22%
PBR $ 14.70 1.76 ▼ 10.69%
JNS $ 14.70 1.19 ▼ 7.49%
AAPL $ 100.11 0.64 ▼ 0.64%
RAD $ 4.95 0.27 ▼ 5.17%
ZNGA $ 2.79 0.04 ▼ 1.41%

As of 9/29/2014, 04:15 PM